Optimized Freezing Solutions for Clinical Application of Cell Therapy Products

Optimized Freezing Solutions for Clinical Application of Cell Therapy Products

STEM-CELLBANKER® and HSC-BANKER® provide optimal freezing solutions for clinical applications

Written byAMSBIO
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
STEM-CELLBANKER® DMSO Free GMP grade is a new chemically defined freezing solution that does not contain DMSO as an anti-freezing agent while  HSC-BANKER® contains only European or US Pharmacopoeia graded ingredients.
AMSBIO

AMSBIO announce new additions and certifications for their market-leading range of clinical grade, chemically defined cryopreservation excipient solutions—STEM-CELLBANKER® and HSC-BANKER®.

STEM-CELLBANKER® DMSO Free GMP grade is a new chemically defined freezing solution that does not contain DMSO as an anti-freezing agent. It was developed for customers who prefer not to use DMSO-containing cryopreservation solution due to the intended application of the samples. STEM-CELLBANKER® DMSO Free GMP grade is manufactured in compliance with JPN, EU, US, and PIC/S GMP guidelines.

Lab manager academy logo

Lab Quality Management Certificate

The Lab Quality Management certificate is more than training—it’s a professional advantage.

Gain critical skills and IACET-approved CEUs that make a measurable difference.

STEM-CELLBANKER® is a chemically defined freezing media optimized for stem cells and iPS cells storage, as well as fragile primary cells. Published data supports its ability to cryopreserve organoids and tissues to allow the recovery of viable cells. STEM-CELLBANKER® GMP grade is manufactured in compliance with JPN, EU, US, and PIC/S GMP guidelines. Free from animal derived components this popular cryopreservation medium contains only chemically defined USP, EP, and JP grade ingredients. Available in both DMSO containing and DMSO-Free formulations, STEM-CELLBANKER® is an optimal freezing solution for basic research and is finding widespread use in the clinical application of cell therapy products.

Manufactured to be completely free of serum and animal derived components, HSC-BANKER® contains only European or US Pharmacopoeia graded ingredients, making it highly suitable for storage of hematopoietic stem cells developed for cell therapy applications.

Recently the master files of HSC-BANKER were accepted by the Center for Biologics Evaluation and Research (CBER) within the US FDA (Food and Drug Administration). Master files are submissions to the FDA used to provide confidential, detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of human drug products. Beneficially they allow researchers to reference material without disclosing master file contents to those parties.

HSC-BANKER® is supplied ready-to-use and requires no special devices, such as a controlled rate freezer, in order to achieve consistently high viabilities following resuscitation from cryopreservation, even over extended long-term storage. HSC-BANKER® significantly increases cell viability while maintaining cell pluripotency, normal karyotype and proliferation ability after freeze-thaw. Evaluated for endotoxins, pH, osmolarity, and mycoplasma contaminants to ensure GMP equivalent quality. HSC-BANKER® is part of the CELLBANKER® range of cryopreservation media for cells, organoids, and tissues.

Interested in life sciences?

Subscribe to our free Life Sciences Newsletter.

Is the form not loading? If you use an ad blocker or browser privacy features, try turning them off and refresh the page.

By subscribing, you agree to receive email related to Lab Manager content and products. You may unsubscribe at any time.

For further information and to watch an introductory video, please visit https://www.amsbio.com/cellbanker-cell-freezing-media/ and https://www.amsbio.com/stem-cell-cryopreservation/ or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / info@amsbio.com. 

Loading Next Article...
Loading Next Article...

CURRENT ISSUE - May/June 2025

The Benefits, Business Case, And Planning Strategies Behind Lab Digitalization

Joining Processes And Software For a Streamlined, Quality-First Laboratory

Lab Manager May/June 2025 Cover Image